Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
VEEV 
Veeva Systems Inc Class A (VEEV)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: VEEV (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -28.33% | Avg. Invested days 36 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 37.08B USD | Price to earnings Ratio 52.63 | 1Y Target Price 266.54 |
Price to earnings Ratio 52.63 | 1Y Target Price 266.54 | ||
Volume (30-day avg) 1376498 | Beta 0.88 | 52 Weeks Range 170.25 - 258.93 | Updated Date 04/1/2025 |
52 Weeks Range 170.25 - 258.93 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.33 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 26% | Operating Margin (TTM) 26.14% |
Management Effectiveness
Return on Assets (TTM) 6.57% | Return on Equity (TTM) 13.63% |
Valuation
Trailing PE 52.63 | Forward PE 31.15 | Enterprise Value 32003975516 | Price to Sales(TTM) 13.5 |
Enterprise Value 32003975516 | Price to Sales(TTM) 13.5 | ||
Enterprise Value to Revenue 11.65 | Enterprise Value to EBITDA 43.79 | Shares Outstanding 162696000 | Shares Floating 149151595 |
Shares Outstanding 162696000 | Shares Floating 149151595 | ||
Percent Insiders 8.9 | Percent Institutions 84.75 |
Analyst Ratings
Rating 4 | Target Price 267.46 | Buy 8 | Strong Buy 13 |
Buy 8 | Strong Buy 13 | ||
Hold 10 | Sell - | Strong Sell 1 | |
Strong Sell 1 |
Upturn AI SWOT
Veeva Systems Inc Class A
Company Overview
History and Background
Veeva Systems was founded in 2007 by Peter Gassner and Matt Wallach. It provides cloud-based software solutions for the global life sciences industry. Veeva's initial focus was on customer relationship management (CRM) for pharmaceutical companies, later expanding into content management, data analytics, and clinical data management. It went public in 2013.
Core Business Areas
- Veeva Commercial Cloud: This segment includes Veeva CRM, Veeva Vault PromoMats, Veeva Align, and other commercial applications used to manage customer relationships, content, and sales processes.
- Veeva Development Cloud: This includes Veeva Vault Clinical, Veeva Vault Regulatory, and other development applications used for clinical trial management, regulatory submissions, and quality management.
- Veeva Data Cloud: Providing data and analytics solutions tailored for the life sciences industry, including Veeva Link and Veeva Compass.
- Veeva Business Consulting: Consulting services which help customers implement the services and also provide guidance.
Leadership and Structure
Peter Gassner is the CEO. The company has a functional organizational structure with departments focused on product development, sales, marketing, and customer success. They have regional leadership teams as well.
Top Products and Market Share
Key Offerings
- Veeva Vault: A unified platform for managing content and data across the product lifecycle. It is a market leader in cloud content management for life sciences. Competitors include Box and OpenText. Veeva claims to serve over 1,700 customers, demonstrating significant market penetration in its core segments. It also has over 870 million in revenue per quarter.
- Veeva CRM: A customer relationship management system specifically designed for the pharmaceutical and biotechnology industries. It's built on the Salesforce platform and includes features like sales force automation and medical affairs. Competitors include Salesforce Health Cloud and Microsoft Dynamics 365.
- Veeva Network: Provides master data management (MDM) solutions to help life sciences companies manage customer and product data. This service aims to provide a single source of truth for customer information. Competitors include IQVIA OneKey.
Market Dynamics
Industry Overview
The life sciences software market is growing due to increasing regulatory requirements, the need for efficient clinical trials, and the shift towards digital transformation. Cloud-based solutions are gaining traction for their scalability and cost-effectiveness.
Positioning
Veeva is a market leader in cloud-based software solutions for the life sciences industry. Its competitive advantages include deep industry expertise, a comprehensive product suite, and a strong customer base.
Total Addressable Market (TAM)
Estimated TAM for life sciences technology is over $20 billion. Veeva is well-positioned to capture a significant portion of this market, targeting digital transformation and operational efficiency within the sector.
Upturn SWOT Analysis
Strengths
- Strong industry expertise
- Comprehensive product suite
- High customer retention rates
- Scalable cloud-based platform
- Established brand reputation
Weaknesses
- Reliance on the life sciences industry
- Potential for vendor lock-in
- High product pricing
- Slower to adopt AI
Opportunities
- Expanding into new geographies
- Developing new products and services
- Acquiring complementary businesses
- Leveraging AI and machine learning
- Increased adoption of cloud solutions
Threats
- Competition from larger software vendors
- Regulatory changes
- Economic downturns
- Data security breaches
- Rapid technological advancements
Competitors and Market Share
Key Competitors
- CRM
- ADSK
- IQV
Competitive Landscape
Veeva has a strong advantage in the life sciences industry due to its specialized product suite and deep industry knowledge. However, larger software vendors such as Salesforce and Oracle pose a significant competitive threat.
Major Acquisitions
Crossix Solutions
- Year: 2019
- Acquisition Price (USD millions): 430
- Strategic Rationale: Expanded Veeva's data and analytics capabilities to help life sciences companies improve their commercial effectiveness.
Growth Trajectory and Initiatives
Historical Growth: Veeva has experienced significant revenue growth due to the increasing demand for cloud-based solutions in the life sciences industry.
Future Projections: Analysts project continued revenue growth for Veeva driven by new product releases, expansion into new markets, and increased adoption of its existing products.
Recent Initiatives: Veeva has recently launched new products focused on AI and data analytics. It has also expanded its services to support virtual clinical trials and data management.
Summary
Veeva is a strong company with a leading position in the life sciences software market. It benefits from high customer retention, a comprehensive product suite, and a growing market. However, it faces competition from larger software vendors and must adapt to changing regulatory requirements and technological advancements.
Similar Companies
- CRM
- ADSK
- CDAY
- MSFT
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Investment decisions should be based on individual research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Veeva Systems Inc Class A
Exchange NYSE | Headquaters Pleasanton, CA, United States | ||
IPO Launch date 2013-10-16 | Founder, CEO & Director Mr. Peter P. Gassner | ||
Sector Healthcare | Industry Health Information Services | Full time employees 7291 | Website https://ww.veeva.com |
Full time employees 7291 | Website https://ww.veeva.com | ||
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud consisting of Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; and Veeva RIM that provides regulatory information management capabilities; as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.